Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

PharmacoEconomics - open

Showing results (11-20 of 653) with videos related to

Pageof 66
Sort By:
Pharmacoeconomics - Open|February 6, 2022
Epidemiologic and Economic Analysis of Rapid Antiretroviral Therapy Initiation with Bictegravir/Emtricitabine/Tenofovir Alafenamide in SpainVicente Estrada, Miguel Górgolas, José A Peña, et al.
Pharmacoeconomics - Open|October 13, 2019
Treatment Satisfaction and Burden of Illness in Patients with Newly Diagnosed Multiple MyelomaRobert M Rifkin, Jill A Bell, Pronabesh DasMahapatra, et al.
Pharmacoeconomics - Open|May 22, 2019
An Evaluation of Diagnosis-Related Group (DRG) Implementation Focused on Cancer DRGs in Greek Public HospitalsPanos Panagiotopoulos, Nikos Maniadakis, George Papatheodoridis, et al.
Pharmacoeconomics - Open|October 20, 2021
The Societal Economic Impact of Secukinumab in First-Line Treatment of Moderate to Severe Plaque Psoriasis in Germany: An Open-Cohort SimulationAhmed H Seddik, Nima Melzer, Foteini Tsotra, et al.
Pharmacoeconomics - Open|October 10, 2021
Budget Impact Analysis of an Epigenetic Test Used for Diagnosing Fetal Alcohol Spectrum Disorder from the Perspective of a Laboratory Budget Holder in Manitoba, CanadaPatrick Berrigan, Geoffrey G Hicks, Wendy J Ungar, et al.
Pharmacoeconomics - Open|July 6, 2019
Indonesian Social Health Insurance Sample Data are Now Available and Accessible for ResearchAnis Fuad
Pharmacoeconomics - Open|May 5, 2019
Health State Utility Data in Cystic Fibrosis: A Systematic ReviewBishal Mohindru, David Turner, Tracey Sach, et al.
Pharmacoeconomics - Open|September 13, 2018
Correction to: Can We Accurately Predict Cost Effectiveness Without Access to Overall Survival Data? The Case Study of Nivolumab in Combination with Ipilimumab for the Treatment of Patients with Advanced Melanoma in EnglandD Lee, A Amadi, J Sabater, et al.
Pharmacoeconomics - Open|August 3, 2023
Correction: Cost-Effectiveness Analysis of Antimicrobial Prescribing in the Treatment of Clostridioides Difficile Infection in EnglandTom Bromilow, Hayden Holmes, Laura Coote, et al.
Pharmacoeconomics - Open|May 18, 2020
Costs of Respiratory Syncytial Virus Hospitalizations in ColombiaJefferson Antonio Buendía, Diana Guerrero Patiño
Pageof 66

Showing results (11-20 of 653) with videos related to

Sort By:
Pageof 66
Pharmacoeconomics - Open|February 6, 2022
Epidemiologic and Economic Analysis of Rapid Antiretroviral Therapy Initiation with Bictegravir/Emtricitabine/Tenofovir Alafenamide in SpainVicente Estrada, Miguel Górgolas, José A Peña, et al.
Pharmacoeconomics - Open|October 13, 2019
Treatment Satisfaction and Burden of Illness in Patients with Newly Diagnosed Multiple MyelomaRobert M Rifkin, Jill A Bell, Pronabesh DasMahapatra, et al.
Pharmacoeconomics - Open|May 22, 2019
An Evaluation of Diagnosis-Related Group (DRG) Implementation Focused on Cancer DRGs in Greek Public HospitalsPanos Panagiotopoulos, Nikos Maniadakis, George Papatheodoridis, et al.
Pharmacoeconomics - Open|October 20, 2021
The Societal Economic Impact of Secukinumab in First-Line Treatment of Moderate to Severe Plaque Psoriasis in Germany: An Open-Cohort SimulationAhmed H Seddik, Nima Melzer, Foteini Tsotra, et al.
Pharmacoeconomics - Open|October 10, 2021
Budget Impact Analysis of an Epigenetic Test Used for Diagnosing Fetal Alcohol Spectrum Disorder from the Perspective of a Laboratory Budget Holder in Manitoba, CanadaPatrick Berrigan, Geoffrey G Hicks, Wendy J Ungar, et al.
Pharmacoeconomics - Open|July 6, 2019
Indonesian Social Health Insurance Sample Data are Now Available and Accessible for ResearchAnis Fuad
Pharmacoeconomics - Open|May 5, 2019
Health State Utility Data in Cystic Fibrosis: A Systematic ReviewBishal Mohindru, David Turner, Tracey Sach, et al.
Pharmacoeconomics - Open|September 13, 2018
Correction to: Can We Accurately Predict Cost Effectiveness Without Access to Overall Survival Data? The Case Study of Nivolumab in Combination with Ipilimumab for the Treatment of Patients with Advanced Melanoma in EnglandD Lee, A Amadi, J Sabater, et al.
Pharmacoeconomics - Open|August 3, 2023
Correction: Cost-Effectiveness Analysis of Antimicrobial Prescribing in the Treatment of Clostridioides Difficile Infection in EnglandTom Bromilow, Hayden Holmes, Laura Coote, et al.
Pharmacoeconomics - Open|May 18, 2020
Costs of Respiratory Syncytial Virus Hospitalizations in ColombiaJefferson Antonio Buendía, Diana Guerrero Patiño
Pageof 66